NDC properties for "dabigatran etexilate 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule" (RxCUI 1723476)
About this data
The tables show NDC propoerties for dabigatran etexilate 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule with the RxCUI 1723476
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for dabigatran etexilate 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule (RxCUI 1723476)
| ANDA | ANDA207961 |
|---|---|
| ANDA | ANDA208070 |
| ANDA | ANDA213879 |
| ANDA | ANDA215233 |
| MMSL_CODE | BD23544 |
| MMSL_CODE | CD23544 |
| RxCUI | 1723476 |
| SNOMEDCT | 860587009 |
| SPL_SET_ID | 13649035-a498-4e31-a7ea-8b18cedceca7 |
| SPL_SET_ID | 3c24e235-218b-438e-9456-42c18ff01913 |
| SPL_SET_ID | 6f79088b-b353-485a-9df4-6f5088f5bd0f |
| SPL_SET_ID | 834a3c5f-b723-4bcb-a560-dc305dd0d829 |
| SPL_SET_ID | dd47a015-ff90-d7a7-8dcb-4e6e31a68071 |
| VUID | 4035289 |
| VUID | 4038532 |
| Prescribable Synonym | dabigatran etexilate 110 MG Oral Capsule |
| RXNAV_STR | dabigatran etexilate 110 MG Oral Capsule |
| RxNorm Name | dabigatran etexilate 110 MG Oral Capsule |
| RxNorm Synonym | dabigatran etexilate 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule |
| Related queries | Interactions (for RxCUI 1723476) |
NDC Properties
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| Packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 31722-666 |
NDC Item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 46708-635 |
NDC Item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| Packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 60505-4349 |
NDC Item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| Packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62332-635 |
NDC Item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| Packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |
NDC Item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| Packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72205-203 |